[go: up one dir, main page]

WO2009053750A3 - Nouvelles formes cristallines et amorphes - Google Patents

Nouvelles formes cristallines et amorphes Download PDF

Info

Publication number
WO2009053750A3
WO2009053750A3 PCT/GB2008/050988 GB2008050988W WO2009053750A3 WO 2009053750 A3 WO2009053750 A3 WO 2009053750A3 GB 2008050988 W GB2008050988 W GB 2008050988W WO 2009053750 A3 WO2009053750 A3 WO 2009053750A3
Authority
WO
WIPO (PCT)
Prior art keywords
amorphous forms
novel crystalline
novel
forms
relates
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/GB2008/050988
Other languages
English (en)
Other versions
WO2009053750A2 (fr
Inventor
Abhay Gaitonde
Bindu Manojkumar
Sandeep Sonawane
Dattatrey Kokane
Vikas Padalkar
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Generics UK Ltd
Mylan Pharmaceuticals Pvt Ltd
Original Assignee
Generics UK Ltd
Mylan Development Centre Pvt Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Generics UK Ltd, Mylan Development Centre Pvt Ltd filed Critical Generics UK Ltd
Publication of WO2009053750A2 publication Critical patent/WO2009053750A2/fr
Publication of WO2009053750A3 publication Critical patent/WO2009053750A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La présente invention concerne de nouvelles formes amorphes et cristallines d'un sel de tartrate de tégasérod ainsi que des procédés de préparation de ces nouvelles formes. L'invention concerne également des compositions pharmaceutiques contenant ces nouvelles formes ainsi que les utilisations desdites compositions dans des méthodes de traitement de patients souffrant de troubles gastro-intestinaux.
PCT/GB2008/050988 2007-10-24 2008-10-24 Nouvelles formes cristallines et amorphes Ceased WO2009053750A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN2106/MUM/2007 2007-10-24
IN2106MU2007 2007-10-24

Publications (2)

Publication Number Publication Date
WO2009053750A2 WO2009053750A2 (fr) 2009-04-30
WO2009053750A3 true WO2009053750A3 (fr) 2009-08-06

Family

ID=40289166

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB2008/050988 Ceased WO2009053750A2 (fr) 2007-10-24 2008-10-24 Nouvelles formes cristallines et amorphes

Country Status (1)

Country Link
WO (1) WO2009053750A2 (fr)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006116953A1 (fr) * 2005-05-02 2006-11-09 Zentiva, A.S. Procede de preparation de tegaserod et de sels sélectionnés dérivés de ce composé
WO2008149154A2 (fr) * 2007-06-05 2008-12-11 Generics [Uk] Limited Nouveaux sels et nouvelles formes polymorphiques

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2059491T3 (es) 1987-06-29 1994-11-16 Duphar Int Res Derivados de indol con anillos condensados.
HUT64023A (en) 1991-03-22 1993-11-29 Sandoz Ag Process for producing aminoguanidine derivatives and pharmaceutical compositions comprising such compounds
GB9721139D0 (en) 1997-10-07 1997-12-03 Glaxo Group Ltd Medicaments

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006116953A1 (fr) * 2005-05-02 2006-11-09 Zentiva, A.S. Procede de preparation de tegaserod et de sels sélectionnés dérivés de ce composé
WO2008149154A2 (fr) * 2007-06-05 2008-12-11 Generics [Uk] Limited Nouveaux sels et nouvelles formes polymorphiques

Also Published As

Publication number Publication date
WO2009053750A2 (fr) 2009-04-30

Similar Documents

Publication Publication Date Title
WO2010055082A3 (fr) Nouvelle forme cristalline de malate de sunitinib
WO2008132139A3 (fr) Nouveaux dérivés hétérocycliques utiles pour le traitement des troubles du système nerveux central
WO2008152099A3 (fr) Aryl/hétarylamides en tant que modulateurs du récepteur ep2
WO2008049116A3 (fr) Indoles substitués
WO2009067686A3 (fr) Hémi-l-malate de sunitinib, polymorphes et leur préparation, polymorphes de malate de sunitinib racémique, compositions contenant une base de sunitinib et de l'acide malique et leur préparation
WO2010092090A3 (fr) Nouveaux sels de la sitagliptine
WO2006024024A3 (fr) Sodium d'ibandronate solide cristallin et ses procedes de preparation
WO2009104021A3 (fr) Nouveaux polymorphes et procédés de préparation
WO2007138282A3 (fr) Nouveaux composés
WO2008070072A3 (fr) Formes, compositions de carvédilol, et leurs procédés de préparation
WO2008083130A3 (fr) Compositions à base de carvédilol
WO2010049449A3 (fr) Nouveaux sels de sunitinib
WO2007052023A3 (fr) Composes
WO2008088779A3 (fr) Formes solides de 5-azacytidine et procédés de préparation de ces dernières
WO2008001201A3 (fr) Compositions pharmaceutiques de clopidogrel
WO2008129501A3 (fr) Compositions pharmaceutiques de duloxetine
WO2010070677A3 (fr) Procédé de préparation de prasugrel et de ses sels pharmaceutiquement acceptables
WO2008021346A3 (fr) Palipéridone pure et ses procédés d'obtention
WO2007098273A3 (fr) Nouvelles formes cristallines d'armodafinil et leur preparation
WO2008137134A3 (fr) Bromhydrate d'élétriptan amorphe et son procédé de préparation, et autres formes de bromhydrate d'élétriptan
WO2006130416A3 (fr) Nouveaux derives 3-spirocyclique indolyle utiles comme modulateurs du recepteur orl-1
WO2010006904A3 (fr) Nouvelles formes cristallines du rabéprazole sodique
WO2008081268A3 (fr) Compositions pharmaceutiques d'entacapone
WO2010079045A3 (fr) Nouveaux sels
WO2008152094A3 (fr) Acétamides substitués en tant que modulateurs du récepteur ep2

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08806795

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 08806795

Country of ref document: EP

Kind code of ref document: A2